title: [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].
abstract: Between July 1981 and June 1987, 533 patients from 7 participating institutions have been entered in a prospective randomized trial to assess the value of adjuvant portal infusion (5-Fluorouracil 500 mg/m2/d x 7 continuous infusion + Mitomycin-C 10 mg/m2 on day 1 as a bolus injection through portal venous catheter) compared to radical surgery alone. The portal venous catheter was placed through any side-branch of the mesenteric venous system during laparotomy for the primary tumour. Using the transabdominal route, there have been no catheter-related complications. Overall hospital mortality in the study was 1.75% and was not influenced by adjuvant treatment. Analysis of 469 eligible patients at a median follow-up of 48 months revealed 39.1% recurrencies in the control group and 31.8% in the infusion group (p = 0.09, logrank). Median survival of control patients is 72 months, of chemotherapy treated patients not yet reached. Significant survival advantages have been detected for those 195 (85%) patients who received full-dose adjuvant chemotherapy (67% versus 53% 5-year survival). Due to the low number of deaths in this trial, prolonged follow-up is needed for definitive survival conclusions.
authors.forename: U
authors.initials: U
authors.lastname: Metzger
authors.forename: U
authors.initials: U
authors.lastname: Laffer
authors.forename: R
authors.initials: R
authors.lastname: Egeli
authors.forename: J
authors.initials: J
authors.lastname: Barras
authors.forename: S
authors.initials: S
authors.lastname: Martinoli
authors.forename: W
authors.initials: W
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Arma
authors.forename: H U
authors.initials: HU
authors.lastname: Bär
authors.forename: W
authors.initials: W
authors.lastname: Schweizer
authors.forename: P
authors.initials: P
authors.lastname: Aeberhard
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D010865:Pilot Projects; D011169:Portal Vein; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
chemical_list: D008937:Mitomycins; D016685:Mitomycin; D005472:Fluorouracil
vernacular_title: Erste Ergebnisse der adjuvanten portalen Leberinfusion nach Radikaloperation von Kolorektalkarzinomen (SAKK-Studie 40/81).